Multinational Companies with Revenue Growth Plans for New Year

It is expected that many of multinational pharmaceutical companies operating in Korea will drive higher revenues for the new year, where the majority of them came short of their last year's revenue objectives due to reasons of prolonged economic slump and of the various pressures affecting their business undertakings.

From the industry sources, it is estimated that Lilly Korea generated the ...